这项交易最初是在去年6月份公布,Coty 计划为 KKW Beauty 扩展现有产品线,引入新的美容品类,包括在 2022 财政年度推出首个护肤系列。(详见《华丽志...查看全文
$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-24 AccNo: 0001437749-18-001089 Size: 157 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-01-24 AccNo: 0001437749-18-001088 Size: 156 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabi Biopharmaceuticals(NABI)$ DEFC14A - Definitive proxy statement, contested solicitations Filed: 2018-01-23 AccNo: 0000921895-18-000230 Size: 355 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise Filed: 2018-01-19 AccNo: 0000921895-18-000216 Size: 352 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-17 AccNo: 0001437749-18-000708 Size: 37 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-01-17 AccNo: 0001437749-18-000707 Size: 37 KBItem 8.01: Other Events 网页链接
$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-16 AccNo: 0001437749-18-000675 Size: 80 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-01-16 AccNo: 0000921895-18-000161 Size: 543 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-16 AccNo: 0001437749-18-000675 Size: 80 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-01-16 AccNo: 0000921895-18-000161 Size: 543 KB 网页链接